BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27841882)

  • 1. Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation.
    Shingu T; Ho AL; Yuan L; Zhou X; Dai C; Zheng S; Wang Q; Zhong Y; Chang Q; Horner JW; Liebelt BD; Yao Y; Hu B; Chen Y; Fuller GN; Verhaak RG; Heimberger AB; Hu J
    Nat Genet; 2017 Jan; 49(1):75-86. PubMed ID: 27841882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
    Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
    Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
    Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
    Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche.
    Zou Y; Niu W; Qin S; Downes M; Burns DK; Zhang CL
    Mol Cell Biol; 2012 Dec; 32(23):4811-20. PubMed ID: 23028043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective calcium sensitivity in immature glioma cancer stem cells.
    Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
    PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
    Giachino C; Boulay JL; Ivanek R; Alvarado A; Tostado C; Lugert S; Tchorz J; Coban M; Mariani L; Bettler B; Lathia J; Frank S; Pfister S; Kool M; Taylor V
    Cancer Cell; 2015 Dec; 28(6):730-742. PubMed ID: 26669487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells.
    Hu YY; Zheng MH; Cheng G; Li L; Liang L; Gao F; Wei YN; Fu LA; Han H
    BMC Cancer; 2011 Feb; 11():82. PubMed ID: 21342503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas.
    Zhu XY; Wang L; Luan SH; Zhang HS; Huang WT; Wang NH
    Neoplasma; 2014; 61(4):401-10. PubMed ID: 24645841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells.
    Kurtsdotter I; Topcic D; Karlén A; Singla B; Hagey DW; Bergsland M; Siesjö P; Nistér M; Carlson JW; Lefebvre V; Persson O; Holmberg J; Muhr J
    Cancer Res; 2017 Sep; 77(18):4985-4997. PubMed ID: 28687615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical Detection of Neural Stem Cells and Glioblastoma Stem Cells in the Subventricular Zone of Glioblastoma Patients.
    Hira VVV; Molenaar RJ; Breznik B; Lah T; Aronica E; Van Noorden CJF
    J Histochem Cytochem; 2021 May; 69(5):349-364. PubMed ID: 33596115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway.
    Yang W; Yu H; Shen Y; Liu Y; Yang Z; Sun T
    Oncotarget; 2016 Jul; 7(27):41505-41526. PubMed ID: 27166258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance.
    Yang W; Wei J; Guo T; Shen Y; Liu F
    Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
    Park HJ; Kim JK; Jeon HM; Oh SY; Kim SH; Nam DH; Kim H
    Mol Cells; 2010 Nov; 30(5):403-8. PubMed ID: 20814749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner.
    Lee JS; Park JR; Kwon OS; Lee TH; Nakano I; Miyoshi H; Chun KH; Park MJ; Lee HJ; Kim SU; Cha HJ
    Neuro Oncol; 2015 Jan; 17(1):95-106. PubMed ID: 25096191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paracaspase MALT1 regulates glioma cell survival by controlling endo-lysosome homeostasis.
    Jacobs KA; André-Grégoire G; Maghe C; Thys A; Li Y; Harford-Wright E; Trillet K; Douanne T; Alves Nicolau C; Frénel JS; Bidère N; Gavard J
    EMBO J; 2020 Jan; 39(1):e102030. PubMed ID: 31774199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.